Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Adrien Buisson

Centre Léon Bérard

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · JOURNAL ARTICLE

ctDNA-based detection of residual disease: implications for management of non-metastatic NSCLC

Frontiers in Oncology

A narrative review synthesizing biological foundations, technological approaches, and current evidence for ctDNA-based MRD detection in non-metastatic NSCLC, without reporting original trial data or effect sizes.

Expert GuidanceCancer Genomics and Diagnostics Lung Cancer Treatments and Mutations Cancer Cells and Metastasis

Study details

DesignNarrative review

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support